Switzerland

Top 4 largest Swiss Companies in the Drug Manufacturers—Specialty & Generic industry by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry from Switzerland by market capitalization with links to their reference stock.

Switzerland Drug Manufacturers—Specialty & Generic Industry Analysis
Top Swiss Companies Switzerland Analysis
World Top Companies World Companies Analysis
⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Top Drug Manufacturers—Specialty & Generic Companies from Switzerland as of Jan. 11, 2021

1. Vifor Pharma AG

Company Profile: Vifor Pharma AG
Market Cap (USD): $11.57 B (Dec. 1, 2022)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Drug Manufacturers—Specialty & Generic

2. Siegfried Holding AG

Company Profile: Siegfried Holding AG
Market Cap (USD): $4.12 B (Jan. 1, 2026)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Drug Manufacturers—Specialty & Generic

3. PolyPeptide Group AG

Company Profile: PolyPeptide Group AG
Market Cap (USD): $876.3 M (July 1, 2025)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Drug Manufacturers—Specialty & Generic

Stay in touch